Skip to main content

Advertisement

SpringerLink
Log in

cIMPACT-NOW update 4: diffuse gliomas characterized by MYB, MYBL1, or FGFR1 alterations or BRAFV600E mutation

  • Correspondence
  • Published:
Acta Neuropathologica Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Bandopadhayay P, Ramkissoon LA, Jain P, Bergthold G, Wala J, Zeid R et al (2016) MYB-QKI rearrangements in angiocentric glioma drive tumorigenicity through a tripartite mechanism. Nat Genet 48:273–282. https://doi.org/10.1038/ng.3500

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Brat DJ, Aldape K, Colman H, Holland EC, Louis DN, Jenkins RB et al (2018) cIMPACT-NOW update 3: recommended diagnostic criteria for “Diffuse astrocytic glioma, IDH-wildtype, with molecular features of glioblastoma, WHO grade IV”. Acta Neuropathol 136:805–810. https://doi.org/10.1007/s00401-018-1913-0

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Broniscer A, Baker SJ, West AN, Fraser MM, Proko E, Kocak M et al (2007) Clinical and molecular characteristics of malignant transformation of low-grade glioma in children. J Clin Oncol 25:682–689. https://doi.org/10.1200/JCO.2006.06.8213

    Article  CAS  PubMed  Google Scholar 

  4. Cancer Genome Atlas Research Network, Brat DJ, Verhaak RG, Aldape KD, Yung WK, Salama SR et al (2015) Comprehensive, integrative genomic analysis of diffuse lower-grade gliomas. N Engl J Med 372:2481–2498. https://doi.org/10.1056/nejmoa1402121

    Article  Google Scholar 

  5. Chiang JCH, Harreld JH, Orr BA, Sharma S, Ismail A, Segura AD et al (2017) Low-grade spinal glioneuronal tumors with BRAF gene fusion and 1p deletion but without leptomeningeal dissemination. Acta Neuropathol 134:159–162. https://doi.org/10.1007/s00401-017-1728-4

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Deng MY, Sill M, Chiang J, Schittenhelm J, Ebinger M, Schuhmann MU et al (2018) Molecularly defined diffuse leptomeningeal glioneuronal tumor (DLGNT) comprises two subgroups with distinct clinical and genetic features. Acta Neuropathol 136:239–253. https://doi.org/10.1007/s00401-018-1865-4

    Article  CAS  PubMed  Google Scholar 

  7. Ferris SP, Hofmann JW, Solomon DA, Perry A (2017) Characterization of gliomas: from morphology to molecules. Virchows Arch 471:257–269. https://doi.org/10.1007/s00428-017-2181-4

    Article  CAS  PubMed  Google Scholar 

  8. Gnekow AK, Falkenstein F, von Hornstein S, Zwiener I, Berkefeld S, Bison B et al (2012) Long-term follow-up of the multicenter, multidisciplinary treatment study HIT-LGG-1996 for low-grade glioma in children and adolescents of the German Speaking Society of Pediatric Oncology and Hematology. Neuro Oncol 14:1265–1284. https://doi.org/10.1093/neuonc/nos202

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Gupta K, Orisme W, Harreld JH, Qaddoumi I, Dalton JD, Punchihewa C et al (2014) Posterior fossa and spinal gangliogliomas form two distinct clinicopathologic and molecular subgroups. Acta Neuropathol Commun 2:18. https://doi.org/10.1186/2051-5960-2-18

    Article  PubMed  PubMed Central  Google Scholar 

  10. Johnson A, Severson E, Gay L, Vergilio JA, Elvin J, Suh J et al (2017) Comprehensive genomic profiling of 282 pediatric low- and high-grade gliomas reveals genomic drivers, tumor mutational burden, and hypermutation signatures. Oncologist 22:1478–1490. https://doi.org/10.1634/theoncologist.2017-0242

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Lin FY, Bergstrom K, Person R, Bavle A, Ballester LY, Scollon S et al (2016) Integrated tumor and germline whole-exome sequencing identifies mutations in MAPK and PI3K pathway genes in an adolescent with rosette-forming glioneuronal tumor of the fourth ventricle. Cold Spring Harb Mol Case Stud 2:a001057. https://doi.org/10.1101/mcs.a001057

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Louis DN, Perry A, Burger P, Ellison DW, Reifenberger G, von Deimling A et al (2014) International Society Of Neuropathology-Haarlem consensus guidelines for nervous system tumor classification and grading. Brain Pathol 24:429–435. https://doi.org/10.1111/bpa.12171

    Article  PubMed  PubMed Central  Google Scholar 

  13. Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee WK et al (2016) The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol 131:803–820. https://doi.org/10.1007/s00401-016-1545-1

    Article  PubMed  Google Scholar 

  14. Louis DN, Wesseling P, Paulus W, Giannini C, Batchelor TT, Cairncross JG et al (2018) cIMPACT-NOW update 1: not otherwise specified (NOS) and not elsewhere classified (NEC). Acta Neuropathol 135:481–484. https://doi.org/10.1007/s00401-018-1808-0

    Article  PubMed  Google Scholar 

  15. Mistry M, Zhukova N, Merico D, Rakopoulos P, Krishnatry R, Shago M et al (2015) BRAF mutation and CDKN2A deletion define a clinically distinct subgroup of childhood secondary high-grade glioma. J Clin Oncol 33:1015–1022. https://doi.org/10.1200/JCO.2014.58.3922

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Ostrom QT, Gittleman H, Liao P, Vecchione-Koval T, Wolinsky Y, Kruchko C et al (2017) CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2010–2014. Neuro Oncol 19:v1–v88. https://doi.org/10.1093/neuonc/nox158

    Article  PubMed  PubMed Central  Google Scholar 

  17. Phillips JJ, Gong H, Chen K, Joseph NM, van Ziffle J, Bastian BC et al (2018) The genetic landscape of anaplastic pleomorphic xanthoastrocytoma. Brain Pathol 29:85–96. https://doi.org/10.1111/bpa.12639

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Qaddoumi I, Orisme W, Wen J, Santiago T, Gupta K, Dalton JD et al (2016) Genetic alterations in uncommon low-grade neuroepithelial tumors: BRAF, FGFR1, and MYB mutations occur at high frequency and align with morphology. Acta Neuropathol 131:833–845. https://doi.org/10.1007/s00401-016-1539-z

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Ramkissoon LA, Horowitz PM, Craig JM, Ramkissoon SH, Rich BE, Schumacher SE et al (2013) Genomic analysis of diffuse pediatric low-grade gliomas identifies recurrent oncogenic truncating rearrangements in the transcription factor MYBL1. Proc Natl Acad Sci USA 110:8188–8193. https://doi.org/10.1073/pnas.1300252110

    Article  PubMed  PubMed Central  Google Scholar 

  20. Reinhardt A, Stichel D, Schrimpf D, Sahm F, Korshunov A, Reuss DE et al (2018) Anaplastic astrocytoma with piloid features, a novel molecular class of IDH wildtype glioma with recurrent MAPK pathway, CDKN2A/B and ATRX alterations. Acta Neuropathol 136:273–291. https://doi.org/10.1007/s00401-018-1837-8

    Article  CAS  PubMed  Google Scholar 

  21. Rivera B, Gayden T, Carrot-Zhang J, Nadaf J, Boshari T, Faury D et al (2016) Germline and somatic FGFR1 abnormalities in dysembryoplastic neuroepithelial tumors. Acta Neuropathol 131:847–863. https://doi.org/10.1007/s00401-016-1549-x

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Rodriguez FJ, Schniederjan MJ, Nicolaides T, Tihan T, Burger PC, Perry A (2015) High rate of concurrent BRAF-KIAA1549 gene fusion and 1p deletion in disseminated oligodendroglioma-like leptomeningeal neoplasms (DOLN). Acta Neuropathol 129:609–610. https://doi.org/10.1007/s00401-015-1400-9

    Article  PubMed  PubMed Central  Google Scholar 

  23. Smits A, Jakola AS (2019) Clinical presentation, natural history, and prognosis of diffuse low-grade gliomas. Neurosurg Clin N Am 30:35–42. https://doi.org/10.1016/j.nec.2018.08.002

    Article  PubMed  Google Scholar 

  24. Stokland T, Liu JF, Ironside JW, Ellison DW, Taylor R, Robinson KJ et al (2010) A multivariate analysis of factors determining tumor progression in childhood low-grade glioma: a population-based cohort study (CCLG CNS9702). Neuro Oncol 12:1257–1268. https://doi.org/10.1093/neuonc/noq092

    Article  PubMed  PubMed Central  Google Scholar 

  25. Sturm D, Bender S, Jones DT, Lichter P, Grill J, Becher O et al (2014) Paediatric and adult glioblastoma: multiform (epi)genomic culprits emerge. Nat Rev Cancer 14:92–107. https://doi.org/10.1038/nrc3655

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Vaubel RA, Caron AA, Yamada S, Decker PA, Eckel Passow JE, Rodriguez FJ et al (2018) Recurrent copy number alterations in low-grade and anaplastic pleomorphic xanthoastrocytoma with and without BRAF V600E mutation. Brain Pathol 28:172–182. https://doi.org/10.1111/bpa.12495

    Article  CAS  PubMed  Google Scholar 

  27. Zhang J, Wu G, Miller CP, Tatevossian RG, Dalton JD, Tang B et al (2013) Whole-genome sequencing identifies genetic alterations in pediatric low-grade gliomas. Nat Genet 45:602–612. https://doi.org/10.1038/ng.2611

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

This paper has been reviewed by the Steering Committee and Clinical Advisory Panel of cIMPACT-NOW and by the International Society of Neuropathology Executive.

The full cIMPACT Steering Committee comprises Drs. Ken Aldape, Dan Brat, David Capper, David W. Ellison, Dominique Figarella-Branger, Cynthia Hawkins, Takashi Komori, David N. Louis, Catriona McLean, Werner Paulus, Arie Perry, Guido Reifenberger, Andreas von Deimling, and Pieter Wesseling.

The cIMPACT Clinical Advisory Panel comprises Drs. Tracy Batchelor, J. Gregory Cairncross, Maryam Fouladi, Stefan Pfister, Michael Weller, and Wolfgang Wick.

ISN executive members who reviewed and commented on the manuscript are Drs. Douglas C Anthony, Herbert Budka, David Hilton, Monika Hofer, Raj Kalaria, Takashi Komori, Seth Love, Laura Chavez Macias, Sung-Hye Park, Audrey Rousseau, and Maria Thom.

Author information

Authors and Affiliations

  1. Department of Pathology, St. Jude Children’s Research Hospital, 262 Danny Thomas Place, Memphis, TN, 38105, USA

    David W. Ellison

  2. Division of Pathology, The Hospital for Sick Children, Toronto, Canada

    Cynthia Hawkins

  3. Hopp-Children’s Cancer Center Heidelberg (KiTZ), 69120, Heidelberg, Germany

    David T. W. Jones & Stefan M. Pfister

  4. Pediatric Glioma Research Group, German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany

    David T. W. Jones

  5. Department of Biostatistics, St. Jude Children’s Research Hospital, 262 Danny Thomas Place, Memphis, TN, 38105, USA

    Arzu Onar-Thomas

  6. Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany

    Stefan M. Pfister

  7. Institute of Neuropathology, Heinrich Heine University, Düsseldorf, Germany

    Guido Reifenberger

  8. Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, 02114, USA

    David N. Louis

Authors
  1. David W. Ellison
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Cynthia Hawkins
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. David T. W. Jones
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Arzu Onar-Thomas
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Stefan M. Pfister
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Guido Reifenberger
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. David N. Louis
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to David W. Ellison.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ellison, D.W., Hawkins, C., Jones, D.T.W. et al. cIMPACT-NOW update 4: diffuse gliomas characterized by MYB, MYBL1, or FGFR1 alterations or BRAFV600E mutation. Acta Neuropathol 137, 683–687 (2019). https://doi.org/10.1007/s00401-019-01987-0

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00401-019-01987-0

Search

Navigation